Insider Transactions Reported by 13 Insiders of AVADEL PHARMACEUTICALS PLC

Symbol
AVDL on Nasdaq
Location
Dublin 2

Insiders trading volume in the past year

AVADEL PHARMACEUTICALS PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Linda Palczuk Director $140,250 12 Feb 2026
Geoffrey Michael Glass Director $140,250 12 Feb 2026
Gregory J. Divis Chief Executive Officer, Director $0 12 Feb 2026
Naseem Amin Director $0 12 Feb 2026
Jerad G. Seurer Gen. Counsel & Corp. Secretary $0 12 Feb 2026
THOMAS S. MCHUGH Chief Financial Officer $0 12 Feb 2026
Mark Anthony McCamish Director $0 12 Feb 2026
Peter J. Thornton Director $0 12 Feb 2026
Weiss Asset Management LP Former 10% Owner $0 -$233,353,092 -100% 13 Feb 2026
Eric J. Ende Director $0 12 Feb 2026
Susan Rodriguez Chief Operating Officer 12 Feb 2026
Douglas J. Williamson Chief Medical Officer 14 Feb 2022
Richard J. Kim Chief Commercial Officer 20 Feb 2024

Recent Insider Transactions by Companies or Individuals for AVADEL PHARMACEUTICALS PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.